MERCK (NYSE: MRK), known as MSD (www.MSD.com) outside the United States and Canada, today announced that ERVEBO [Ebola Zaire Vaccine (rVSVΔ-ZEBOV-GP live)] has been awarded prequalification status by the World Health Organization (WHO).
Diseases
Novartis announces new strategy to provide innovative medicines to more patients in sub-Saharan Africa
Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa (SSA), which is home to the largest underserved patient population in the world.
Ebola vaccine approved in Europe
After more than two decades of research, the world finally has an approved Ebola vaccine.
Research shows using both marijuana and alcohol during early pregnancy may disrupt fetal development
New preclinical research reported in animal models shows that exposure to compounds found in marijuana called cannabinoids (CBs), which includes cannabidiol (CBD) and tetrahydrocannabinol (THC), during early pregnancy can cause malformations in the developing embryo.
NIH-funded study finds teens prefer mint and mango vaping flavors
A new analysis suggests that teens prefer mint and mango as their vaping flavors of choice for e-cigarettes.
NIH Researchers Estimate 17% of Food-Allergic Children Have Sesame Allergy
Investigators at the National Institutes of Health have found that sesame allergy is common among children with other food allergies, occurring in an estimated 17% of this population.
New compound helps find early signs of liver damage
A new compound that binds to, and enables MRI imaging of, liver cells in the early stage of disease, has been developed by scientists supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the NIH.
